Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 18, 2002

View Archived Issues

Inhibition of breast cancer cell growth in vitro with c-myc oligonucleotides and ICI-182780

Novel anticancer therapy: paclitaxel combined with an MEK inhibitor enhances apoptosis

Topical liposomal tacrolimus effective in murine model of immune-mediated skin disorders

Keratinocytes from papillomavirus-infected skin express antimicrobial peptide

Antiangiogenic effects of zoledronic acid demonstrated in vitro and in vivo

Novel HIV protease inhibitors identified at Pharmacor

Toagosei presents novel ammonium salts with antibacterial, antifungal and antiprotozoal activity

Novel CRF antagonists and their use in depression, anxiety, etc.

cGMP-selective PDE inhibitors under study at Bayer

New zinc complexes with dual activity as insulin mimetics and antihypertensive agents

Novel PDE5 inhibitors developed by Lilly Icos researchers

Japan Energy describes TNF-alpha and IL-6 production inhibitors

Memory-improving compounds covered by Zenyaku Kogyo patent

Bayer Diagnostics completes Visible Genetics acquisition

ActivBiotics and DepoMed to develop rifalazil for gastrointestinal bacterial infections

New class of compounds for drug-resistant HIV discovered at Pharmacor

Additional data reported on the efficacy and safety of aripiprazole in schizophrenia

Inhibitors of two-component regulatory system as potentially novel antibacterial agents

Ras inhibitor FTS reduces autoantibodies in animal models of APS

EGFR-targeted MAb improves response to radiotherapy in SCCHN

Doxovir 1% eliminates HPV11 from foreskin grafts in mouse model

Epicyte receives grant for production of HIV hybrid antibodies

FluINsure challenge study cleared in U.K.

Long-term safety data for RG-1068

German approval for Ezetrol

Columbia and Ardana enter European marketing partnership for Striant

Canadian IND cleared for Generex's buccal fentanyl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...